Illumina Taps Former FDA Commissioner Scott Gottlieb for Board of Directors Role

Since leaving the U.S. Food and Drug Administration (FDA), former Commissioner Scott Gottlieb has been tapped by pharmaceutical companies for a number of boards of director positions due to his regulatory expertise.

This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4. Illumina Chief Executive Officer Francis deSouza said the gene-sequencing company “will benefit from Scott’s expertise in healthcare and public policy as we work to accelerate the adoption and impact of genomics into the standard of care in oncology, reproductive health and other clinical areas.”